ClinicalTrials.Veeva

Menu

Predictive Clinical and Biological Parameters in Gynecological Cancer (GC-BIO)

I

Institut Paoli-Calmettes

Status

Enrolling

Conditions

Endometrium Cancer
Ovarian Cancer
Cervix Cancer

Treatments

Other: gynecological cancer

Study type

Interventional

Funder types

Other

Identifiers

NCT01977274
GC-BIO-IPC 2013-010

Details and patient eligibility

About

Research of predictive clinical and biological factors in breast cancer : genomic, proteomic, mutation

Enrollment

300 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • gynecological cancer suspicion
  • age > 18
  • signed informed consent

Exclusion criteria

  • emergency

Exclusion criteria after histological exam Any diagnosis that is not a gynecological cancer (ovarian, cervix, endometrium).

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

300 participants in 1 patient group

gynecological cancer
Experimental group
Description:
blood and tumor samples
Treatment:
Other: gynecological cancer

Trial contacts and locations

1

Loading...

Central trial contact

Dominique GENRE, MD; Margot BERLINE, MSc, MBA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems